Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.
This report contains market size and forecasts of ICAD (Intracranial Atherosclerotic Disease) Pathology in global, including the following market information:
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Sales, 2017-2022, 2023-2028, (Units)
Global top five ICAD (Intracranial Atherosclerotic Disease) Pathology companies in 2021 (%)
The global ICAD (Intracranial Atherosclerotic Disease) Pathology market was valued at 179 million in 2021 and is projected to reach US$ 315.3 million by 2028, at a CAGR of 8.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology include Stryker, Balt, TERUMO, MicroPort and Acandis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment Percentages, by Type, 2021 (%)
Stent
PTA Balloon
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies ICAD (Intracranial Atherosclerotic Disease) Pathology revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies ICAD (Intracranial Atherosclerotic Disease) Pathology revenues share in global market, 2021 (%)
Key companies ICAD (Intracranial Atherosclerotic Disease) Pathology sales in global market, 2017-2022 (Estimated), (Units)
Key companies ICAD (Intracranial Atherosclerotic Disease) Pathology sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Stryker
Balt
TERUMO
MicroPort
Acandis

LEAVE A REPLY

Please enter your comment!
Please enter your name here